Drug Coverage Harder to Find for Traditional Medicare Enrollees

Feb. 3, 2025, 10:05 AM UTC

Declining enrollment, fewer plan offerings, and persistently higher premiums are raising concerns about the stability and viability of the market for Medicare stand-alone prescription drug plans.

Known simply as “PDPs,” the plans provide drug coverage for beneficiaries in traditional, fee-for-service Medicare. They also provide premium-free “benchmark plans” for fee-for-service beneficiaries who receive the Medicare prescription drug Low Income Subsidy. Medicare Advantage drug plans provide both medical and drug coverage for enrollees, who account for more than half of all Medicare beneficiaries.

Major insurers like Cigna Corp., Centene Corp., Aetna Inc., and Humana Inc. offer both PDPs and ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.